
Photo by Innerbody Research
You could probably guess why nootropics, or “smart drugs,” constitute such a popular health market.1 We could all do with a little more brain power, after all.
Better brain function is exactly what the peptide Semax was made to deliver. Developed in Russia in the 1980s, Semax stands out as a promising therapy for cerebral health and neurodegenerative disorders. But because widespread pharmaceutical use and the relevant research are largely limited to its native region, reliable information about its therapeutic applications is somewhat scarce outside of Russia and Eastern Europe. Apart from a relatively light body of English-language scientific literature, a lot of the reportage on Semax comes from niche influencers and online vendors with questionable pedigrees.
So we’ve written this guide with the goal of unifying key takeaways from the most reliable research on Semax to date, including our interactions with some of the few reputable clinics that offer it in the U.S. By the end of it, you should have the clearest possible understanding of Semax’s potential benefits, risks, and availability.
And if you decide you’re interested in Semax, we think your best option right now is a LegitScript-certified telehealth provider called Protocole.
The Protocole platform can connect you with a clinician who can guide you through your treatment options.
It starts with a consultation, in which the clinician listens to your health goals and helps personalize a suite of suitable therapeutic peptides for you. If Semax is among the recommendations, then a licensed physician will review your eligibility for Protocole's Semax/Selank treatment bundle. Approved prescriptions are sent to a state-licensed 503A compounding pharmacy for fulfillment, and your medication should arrive at your doorstep in a matter of days.
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles.
This Semax guide is part of our ongoing series on therapeutic peptides, an endeavor to which we’ve devoted over 1,000 hours of research and writing so far. As with all of our guides, we familiarized ourselves with Semax through the available scientific literature. Where pertinent, we cross-referenced the studies and reviews on Semax with supplemental research on associated factors, such as the role of the natural peptide that Semax mimics and the efficacy of the nasal route of administration.
Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy and will continue to be monitored for updates by our editorial team.
Semax is a peptide analog, or a synthetic and modified version of a naturally occurring peptide. It specifically mimics a fragment of the pituitary chemical adrenocorticotropic hormone (ACTH). While ACTH is best known for its endocrine activity (triggering the release of other hormones, namely cortisol and androgens),2 it also has neurotrophic effects (i.e., it supports the development and survival of neurons).3
Semax mimics only a fragment of ACTH, not the whole molecule, so it doesn’t behave exactly the same. According to the Alzheimer’s Drug Discovery Foundation (ADDF), Semax delivers the neurotrophic effects of ACTH but not the hormonal/endocrine ones,4 so it circumvents the onset of symptoms associated with overactive ACTH secretion (e.g., upper-body obesity, “buffalo” hump, high blood pressure).5
Semax can be administered effectively via injection or intranasal (through-the-nose) administration. This is a point of differentiation from many other therapeutic peptides, which are often less effective through non-injectable routes because their molecules are too large to pass reliably into the bloodstream.6
Further going against the grain, Semax appears to be more effective when administered intranasally, at least in terms of its nootropic benefit. In a 2012 study published in Neuroscience and Behavioral Physiology, researchers found that intranasal Semax yielded a more pronounced improvement in learning in rodent subjects compared to intraperitoneal injection.7 The downside was that intranasal administration provided no analgesic (pain-relieving) action, which is one of Semax’s secondary therapeutic uses.
Semax is a neuropeptide,8 a class of signaling molecules in the brain with numerous functions.9 In Russia and Eastern Europe, Semax’s primary uses are nootropic (cognition-enhancing), neuroprotective (brain-preserving), anxiolytic (anxiety-reducing), antidepressant (mood-improving), and immunomodulatory (immune system–modifying). Below, we discuss the literature that supports Semax’s applications in these areas:
There’s no consensus as to Semax’s nootropic mechanisms of action. Some researchers have proposed that it increases either the metabolism of acetylcholine or the circulation of monoamines such as dopamine and serotonin,10 as demonstrated in rodent studies.11 These monoamines have distinct motivating actions that can lead to increased cognitive function: dopamine drives you to associate cognitive tasks with a sense of reward,12 while serotonin may help you look past the “aversive costs” (e.g., time and effort) that could discourage you from beginning a cognitive task.13
Another potential mechanism behind Semax’s nootropic action is its modulation of brain-derived neurotrophic factor (BDNF), a protein described as a “key molecule involved in plastic changes related to learning and memory.”14 Again in rodent studies, Semax administration has significantly increased BDNF expression in the brain,15 suggesting that the peptide can help users adapt to new information and form new neural connections in response. Accordingly, Semax may even be a potential therapeutic agent for attention-deficit/hyperactivity disorder (ADHD).16
By increasing BDNF expression in the brain, Semax is also a promising agent against neurodegeneration,17 such as from disease, stroke, or aging. Indeed, BDNF depletion is associated with increased biomarkers for Alzheimer’s disease,18 poor stroke recovery,19 and senescent cognitive decline.20 Semax’s therapeutic potential to treat these conditions finds support in human trials, including a 1997 study that saw improved neurological function in patients with ischemia after Semax administration,21 as well as a 2018 study demonstrating increased brain activity (suggesting positive implications for people with Alzheimer’s and those recovering from stroke).22 23 24
With low BDNF also being linked to anxiety and depression,25 26 Semax has been studied as a potential treatment for such mood conditions. A 2024 study of ACTH analogs in rodents showed that coadministration of Semax with another analog successfully reduced the severity of depressive symptoms and increased BDNF levels in the brain,27 while an earlier study from 2010 found that Semax normalized behavior in rats induced with anxiety and depression.28
In a paper for a 2017 study of Semax in rats, researchers claim that “the immune response is the process most markedly affected by the peptide” owing to its ability to enhance the antigen presentation signaling pathway, influence the synthesis of immunoglobulins, and stimulate the interferon-signaling pathways.29 What that means, respectively, is that Semax helps (a) trigger immune responses, (b) create antibodies, and (c) strengthen resistance to viral infection.
Varying degrees of research indicate that Semax can provide some benefits outside of its primary therapeutic uses. Namely, it has been studied for:
Safety information on Semax is meager outside of Russian-language scientific literature. The relatively little information we have comes from the ADDF and a 2022 review on Russian peptide biopharmaceuticals.
The ADDF report, published in 2020, notes “very little human evidence for potential side effects” despite “many preclinical trials,” and the authors presume a low side effect profile owing to Semax’s purportedly common use in Russia. Only two common adverse events are mentioned: discoloration of the nasal cavity with intranasal administration (approximately 10% of patients) and increased blood glucose levels in people with diabetes.4
The 2022 review, largely in corroboration of the ADDF’s conclusion, states that Semax has “low toxicity,” is not habit-forming, and has no ill effects on:34
Because Semax isn’t FDA-approved or even widely available outside of Russia and Eastern Europe, the curious Westerner may be tempted to purchase the peptide from an online retailer. Too many of these online retailers will offer you Semax without requiring a prescription, as they deal in research-grade peptides. And you don’t want that.
Research-grade peptides, which aren’t subject to the same quality controls as their pharmaceutical-grade counterparts, are for laboratory use only. Scientists can use them in experiments on cells and animal models, but they pose health risks in humans owing to their low purity levels.35 By injecting or inhaling research-grade Semax, you may put yourself in danger of an immunogenetic reaction,36 in which your immune system perceives the peptide as a threat and mounts a potentially life-threatening anaphylaxis-like reaction against it.
On a tangential note, in July 2026, Semax was among the six therapeutic peptides on which an FDA advisory panel voted to lift restrictions. The panel’s vote amounts to a recommendation, not an approval, but it could lead to wider availability of pharmaceutical-grade Semax and an attendant reduction in the use of dangerous research-grade versions.
Despite lacking FDA approval or widespread use, we’ve been able to get a good sense of the Semax experience, thanks largely to the relationships we’ve established with peptide clinics and providers over the years. Below is a broad yet accurate view of what to expect (should you qualify for a Semax prescription).
Clinical studies in humans have administered Semax starting at doses of 1.2mg (intranasal) and ranging up to 1mg per kilogram (injectable).4 For medical use, the actual dosage can be much lower or higher depending on your desired health outcome.
Intranasal Semax will come in a ready-to-use vessel similar to, say, a Mucinex bottle, whereas the injectable version may come as either a premixed solution or a dry powder needing reconstitution.
Though dosing frequencies may vary, a common protocol entails daily nasal administration or near-daily injections.
As with many therapeutic peptides, your protocol may require that you cycle your Semax use — several months of regular administration, followed by a one-month break. This pattern can help maintain efficacy by preventing drug tolerance.
Some users report feeling cognitive enhancement benefits in as little as 30 minutes after Semax administration. Pain relief benefits may have a similarly rapid onset.
Any neuroprotective, immunomodulatory, and cardiovascular benefits are likely to take much longer to take effect — 2-4 weeks at least — and aren’t likely to be apparent to you in a daily-quality-of-life kind of way.
Semax ought to remain stable under refrigerated conditions (the U.K.’s National Institute for Biological Standards and Control recommends a storage temperature of 4°C, or 39°F).37
Intranasal Semax can be stable at higher temperatures and doesn’t always need to be refrigerated — it may depend on the manufacturer. But at the very least, you should keep the bottle in a cool, dry environment below 10°C (50°F) and out of direct sunlight.
People who stand to gain the most benefit from Semax are those who have or are at risk for:
Interestingly, despite its potential as an anxiolytic, Semax may not be indicated for people with anxiety disorders. In a 1996 study, researchers noted an “anxiogenic [anxiety-worsening] component in the spectrum of Semax’s behavioral effects” and suggested that the peptide would be optimally useful in people without elevated anxiety levels.38
Other populations for whom Semax is contraindicated include people with diabetes (Semax may increase their blood sugar levels) and pregnant or breastfeeding women (there isn’t enough research to say whether Semax is safe for the developing fetus or child).4
Currently, because Semax isn’t an FDA-approved drug, there’s a very limited number of safe places to get it in the United States. Most of the go-to sources are in-person clinics. While you can find online retailers selling Semax powder or spray, most of these right now are certain to be pushing research-grade products that (it must be reiterated) are not suitable for human use.
But though they’re scarce, there are reputable online platforms for discovering whether Semax is right for you, and the one we recommend is a LegitScript-certified telehealth platform called Protocole. They work with licensed physicians and state-licensed 503A pharmacies that can prescribe and fulfill pharmaceutical-grade Semax in combination with Selank, a similar nootropic peptide, contingent on review and approval.
To get started, just schedule a low-cost consultation through the Protocole platform. The consultation is how a Protocole-affiliated clinician can gather details about your health goals and initially determine whether you're indicated for Semax, and the consultation fee goes toward your order if you decide to move forward.
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.